Home

Páfrány Beismerni töredék a promising circulating marker for bone metastasis response Külön Lada Kapcsolat

Combinatorial targeting of cancer bone metastasis using mRNA engineered  stem cells - eBioMedicine
Combinatorial targeting of cancer bone metastasis using mRNA engineered stem cells - eBioMedicine

Frontiers | Predictive and Prognostic Biomarkers for Lung Cancer Bone  Metastasis and Their Therapeutic Value
Frontiers | Predictive and Prognostic Biomarkers for Lung Cancer Bone Metastasis and Their Therapeutic Value

Molecular mechanisms and clinical management of cancer bone metastasis |  Bone Research
Molecular mechanisms and clinical management of cancer bone metastasis | Bone Research

Bone Metastasis: Find Your Niche and Fit in: Trends in Cancer
Bone Metastasis: Find Your Niche and Fit in: Trends in Cancer

Liquid biopsy: a step closer to transform diagnosis, prognosis and future  of cancer treatments | Molecular Cancer | Full Text
Liquid biopsy: a step closer to transform diagnosis, prognosis and future of cancer treatments | Molecular Cancer | Full Text

RANKL: A promising circulating marker for bone metastasis response
RANKL: A promising circulating marker for bone metastasis response

From latency to overt bone metastasis in breast cancer: potential for  treatment and prevention - Salvador - 2019 - The Journal of Pathology -  Wiley Online Library
From latency to overt bone metastasis in breast cancer: potential for treatment and prevention - Salvador - 2019 - The Journal of Pathology - Wiley Online Library

Extracellular vesicles as a promising biomarker resource in liquid biopsy  for cancer
Extracellular vesicles as a promising biomarker resource in liquid biopsy for cancer

Updates on liquid biopsy: current trends and future perspectives for  clinical application in solid tumors
Updates on liquid biopsy: current trends and future perspectives for clinical application in solid tumors

Circulating tumour cells in the -omics era: how far are we from achieving  the 'singularity'? | British Journal of Cancer
Circulating tumour cells in the -omics era: how far are we from achieving the 'singularity'? | British Journal of Cancer

Cancer Stem Cell (CSC) Inhibitors in Oncology—A Promise for a Better  Therapeutic Outcome: State of the Art and Future Perspectives | Journal of  Medicinal Chemistry
Cancer Stem Cell (CSC) Inhibitors in Oncology—A Promise for a Better Therapeutic Outcome: State of the Art and Future Perspectives | Journal of Medicinal Chemistry

Frontiers | Circulating Tumor Cells: A Promising Biomarker in the  Management of Nasopharyngeal Carcinoma
Frontiers | Circulating Tumor Cells: A Promising Biomarker in the Management of Nasopharyngeal Carcinoma

Frontiers | Cell-Free DNA: Hope and Potential Application in Cancer
Frontiers | Cell-Free DNA: Hope and Potential Application in Cancer

Cancers | Free Full-Text | Hypoxia in Lung Cancer Management: A  Translational Approach
Cancers | Free Full-Text | Hypoxia in Lung Cancer Management: A Translational Approach

IJMS | Free Full-Text | Understanding the Progression of Bone Metastases to  Identify Novel Therapeutic Targets
IJMS | Free Full-Text | Understanding the Progression of Bone Metastases to Identify Novel Therapeutic Targets

Cancers | Free Full-Text | Radium-223 Treatment of Patients with Metastatic  Castration Resistant Prostate Cancer: Biomarkers for Stratification and  Response Evaluation
Cancers | Free Full-Text | Radium-223 Treatment of Patients with Metastatic Castration Resistant Prostate Cancer: Biomarkers for Stratification and Response Evaluation

Subtyping of metastatic breast cancer based on plasma circulating tumor DNA  alterations: An observational, multicentre platform study -  eClinicalMedicine
Subtyping of metastatic breast cancer based on plasma circulating tumor DNA alterations: An observational, multicentre platform study - eClinicalMedicine

Imaging Bone Metastases in Breast Cancer: Staging and Response Assessment |  Journal of Nuclear Medicine
Imaging Bone Metastases in Breast Cancer: Staging and Response Assessment | Journal of Nuclear Medicine

Human prostate cancer bone metastases have an actionable immunosuppressive  microenvironment - ScienceDirect
Human prostate cancer bone metastases have an actionable immunosuppressive microenvironment - ScienceDirect

Prostate-specific membrane antigen in circulating tumor cells is a new poor  prognostic marker for castration-resistant prostate cancer | PLOS ONE
Prostate-specific membrane antigen in circulating tumor cells is a new poor prognostic marker for castration-resistant prostate cancer | PLOS ONE

Assessing response to treatment of bone metastases from breast cancer: what  should be the standard of care? - ScienceDirect
Assessing response to treatment of bone metastases from breast cancer: what should be the standard of care? - ScienceDirect

Current advances in prognostic and diagnostic biomarkers for solid cancers:  Detection techniques and future challenges - ScienceDirect
Current advances in prognostic and diagnostic biomarkers for solid cancers: Detection techniques and future challenges - ScienceDirect

IJMS | Free Full-Text | Circulating Tumor DNA in Precision Oncology and Its  Applications in Colorectal Cancer
IJMS | Free Full-Text | Circulating Tumor DNA in Precision Oncology and Its Applications in Colorectal Cancer

Frontiers | Cross Talk Between Macrophages and Cancer Cells in the Bone  Metastatic Environment
Frontiers | Cross Talk Between Macrophages and Cancer Cells in the Bone Metastatic Environment